Safinamide Mesilate

safinamide · Eisai Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Safinamide Mesilate, covering 2024-09-23 to 2024-09-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Safinamide Mesilate as Add-on Therapy to Levodopa in Parkinson's Disease Participants With Motor Fluctuation in South Korea [Phase 4]

See pricing